Patients with Takayasu arteritis should be evaluated promptly for Takayasu retinopathy even with good vision because stenosis of major vessels off the aorta is associated with worse visual prognosis.
Acute idiopathic maculopathy (AIM), originally termed unilateral AIM, is a rare inflammatory disorder that typically affects young adults (mean age, 32 y; range, 15 to 45 y) and is characterized by acute, severe, unilateral vision loss preceded by a flu-like illness. Men and women are affected equally. Patients generally present with visual acuity of r20/200 and complain of central metamorphopsia and/or scotoma formation that is attributable to an exudative macular detachment. There may also be hypopigmentation of the retinal pigment epithelium, which may simulate the appearance of choroidal neovascularization (CNV) (Fig. 1). 1 Papillitis, a few vitreous cells, subretinal exudation, and bilaterality have also been observed in AIM, whereas eccentric macular lesions have been noted in cases with milder vision loss (20/60 to 20/100). 2 Most cases resolve spontaneously with near-complete recovery of vision (20/25 or better) over a period of 3 weeks to 6 months. After resolution of the macular detachment, a ''bull's-eye'' pattern composed of retinal pigment epithelial (RPE) hyperpigmentation surrounded by hypopigmented atrophic changes develops at the site of the antecedent neurosensory detachment (Fig. 2). To date, there has been only 1 reported case with recurrent episodes of AIM. 3 Rarely, secondary CNV has occurred after resolution of AIM. The authors have seen a case of secondary CNV after AIM that responded well to intravitreal anti-vascular endothelial growth factor therapy.The flu-like illness that precedes AIM suggests a viral cause. The coxsackie virus has been implicated in the pathogenesis of AIM,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.